Alexander Nowak
Stock Analyst at Craig-Hallum
(2.98)
# 2,019
Out of 5,072 analysts
46
Total ratings
50%
Success rate
9.87%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $100.35 | +7.62% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $9.83 | +123.80% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $237.12 | -33.79% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.65 | +122.22% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $27.50 | +107.27% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $17.81 | -15.78% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $9.12 | -12.28% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.65 | +990.91% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $20.73 | +141.20% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $12.00 | +1,233.33% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $101.45 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.70 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.43 | +352.67% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $64.63 | +70.20% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.04 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.24 | +13,292.86% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.25 | +202.70% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $100.35
Upside: +7.62%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $9.83
Upside: +123.80%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $237.12
Upside: -33.79%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.65
Upside: +122.22%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $27.50
Upside: +107.27%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $17.81
Upside: -15.78%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $9.12
Upside: -12.28%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.65
Upside: +990.91%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $20.73
Upside: +141.20%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $12.00
Upside: +1,233.33%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $101.45
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.70
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.43
Upside: +352.67%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $64.63
Upside: +70.20%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.04
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.24
Upside: +13,292.86%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.25
Upside: +202.70%